Fuji Yakuhin and Sanwa Kagaku Apply For FYX-051
This article was originally published in PharmAsia News
Executive Summary
Fuji Yakuhin and Sanwa Kagaku Research announced June 28 they submitted an application in Japan for the hyperuricemia/gout treatment FYX-051 June 26.